Skip to main content
. 2007 Jan-Feb;14(1):25–29. doi: 10.1155/2007/161652

TABLE 3.

Days to discontinuation for all, experienced (Exp) and naive patients

Drug 12 months
18 months
All Exp Naive All Exp Naive
Formoterol 68±70 71±72 51±51 96±112 102±114 61±82
Form-Budes 74±70 78±72 54±54 96±105 102±108 64±81
Ipratropium 58±59 60±59 54±58 70±85 73±87 64±80
Iprat-Salbut 57±59 61±63 51±54 71±89 78±95 62±80
Salmeterol 76±70 76±71 66±66 103±112 104±111 97±122
Salmet-Flut 82±75 88±77 55±56 114±119 122±123 69±87
Tiotropium 96±78 97±79 79±71 145±133 150±135 103±108

Data presented as mean ± SD days. All Exp versus naive groups, P<0.00001. Form-Budes Formoterol and budesonide; Iprat-Salbut Ipratropium and salbu-tamol; Salmet-Flut Salmeterol and fluticasone